A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF BAXDROSTAT IN ADULT PARTICIPANTS WITH PRIMARY ALDOSTERONISM

Registry ID

D6974C00001

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

ASTRAZENECA CANADA INC

Start date

2026-01-22

Last update

2025-06-03

Conditions

• PRIMARY ALDOSTERONISM

View on source registry